Prevencio utilizes Artificial Intelligence + Multi-Proteomic Biomarkers + Proprietary Algorithms to deliver cardiovascular diagnostic & prognostic tests that are significantly more accurate than standard-of-care stress tests, individual biomarkers, genetic markers and clinical risk scores. The six blood tests in our product pipeline (with more coming) are:
1. HART CAD – test for obstructive coronary artery disease diagnosis
2. HART CVE – test for 1-year risk of heart attack, stroke or cardiac death
3. HART PAD – test for peripheral artery disease diagnosis
4. HART AS – test for aortic valve stenosis
5. HART AMP – test for risk of amputation
6. HART AKI – test for risk of acute kidney injury
Prevencio has presented 7 times at ACC, AHA, ESC and ADA & has 5 publications in peer-reviewed journals.